BLBD
BLBD: Sanfrey Jeffrey Scott discloses a sale
Sanfrey Jeffrey Scott reported Sale in Blue Bird Corp: 4000 units of Common Stock, par value $0.0001 per share, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
LoadingLoadingLoadingBLBD
Sanfrey Jeffrey Scott reported Sale in Blue Bird Corp: 4000 units of Common Stock, par value $0.0001 per share, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
CUEN
Maimon Shalom Arik reported Purchase in Cuentas Inc.: 100 units of Common Stock, dated 2026-09-04. The full Form 4 contains 10 transaction entries.
KLTR
Azaria Eynav reported Sale in KALTURA INC: 7116 units of Common Stock, dated 2026-09-16. The full Form 4 contains 2 transaction entries.
CBU
Vaccaro John A reported Grant or award in COMMUNITY FINANCIAL SYSTEM, INC.: 346.5031 units of Deferred Stock (Deferred Compensation) (derivative), dated 2026-09-17. The full Form 4 contains 1 transaction entry.
YB
WAN HUI RUI reported Grant or award in Yuanbao Inc.: 30000 units of Options (Right to Buy) (derivative), dated 2026-09-16. The full Form 4 contains 5 transaction entries.
YB
Wang Bo Ethan reported Grant or award in Yuanbao Inc.: 90000 units of Options (Right to Buy) (derivative), dated 2026-09-16. The full Form 4 contains 5 transaction entries.
YB
Sun Shuli reported Grant or award in Yuanbao Inc.: 90000 units of Options (Right to Buy) (derivative), dated 2026-09-16. The full Form 4 contains 5 transaction entries.
YB
Fang Rui reported Grant or award in Yuanbao Inc.: 480000 units of Options (Right to Buy) (derivative), dated 2026-09-16. The full Form 4 contains 5 transaction entries.
KRMN
Twitty Stephen reported Purchase in Karman Holdings Inc.: 275 units of Common Stock, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
KRMN
Petryszyn Mary D reported Purchase in Karman Holdings Inc.: 500 units of Common Stock, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
KRMN
Stinnett David reported Purchase in Karman Holdings Inc.: 27000 units of Common Stock, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
AIM
Equels Thomas K reported Purchase in AIM ImmunoTech Inc.: 24000 units of Common Stock, dated 2026-09-17. The full Form 4 contains 1 transaction entry.
STNG
Adelborg Auste reported Sale in Scorpio Tankers Inc.: 6834 units of Common shares, dated 2026-09-17. The full Form 4 contains 1 transaction entry.
AXIA3
de Bittencourt Marinho Gisomar Francisco reported Grant or award in AXIA Energia S.A.: 224 units of Common Shares, dated 2026-09-16. The full Form 4 contains 2 transaction entries.
BZUN
Qiu Wenbin reported Purchase in Baozun Inc.: 7300 units of American Depositary Shares, dated 2026-09-16. The full Form 4 contains 2 transaction entries.
RDWR
Aviv David Meleh reported Sale in RADWARE LTD: 15000 units of Ordinary Shares, dated 2026-09-17. The full Form 4 contains 1 transaction entry.
BILI
Fan Xin reported Grant or award in Bilibili Inc.: 400000 units of Class Z ordinary shares, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
ICLR
CLIMAX JOHN DR reported Exercise or conversion in ICON PLC: 5005 units of Ordinary Shares, dated 2026-09-16. The full Form 4 contains 3 transaction entries.
SMWB
Offer Or reported Sale in SIMILARWEB LTD.: 45719 units of Ordinary Shares, dated 2026-09-16. The full Form 4 contains 2 transaction entries.
XP
Dos Santos Bruno Constantino Alexandre reported Sale in XP Inc.: 123257 units of Class A Common Shares, dated 2026-09-16. The full Form 4 contains 1 transaction entry.
TVTX
Cline Christopher R. reported Exercise or conversion in Travere Therapeutics, Inc.: 20000 units of Common Stock, dated 2026-09-15. The full Form 4 contains 6 transaction entries.
TVTX
Dube Eric M reported Exercise or conversion in Travere Therapeutics, Inc.: 95666 units of Common Stock, dated 2026-09-15. The full Form 4 contains 14 transaction entries.
TVTX
REED ELIZABETH E reported Exercise or conversion in Travere Therapeutics, Inc.: 37500 units of Common Stock, dated 2026-09-15. The full Form 4 contains 6 transaction entries.
TVTX
Inrig Jula reported Exercise or conversion in Travere Therapeutics, Inc.: 32395 units of Common Stock, dated 2026-09-15. The full Form 4 contains 6 transaction entries.
